Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hormone Treatment-naïve Participants With Prostate Cancer × relugolix × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 32 Leiomyoma 9 Menorrhagia 5 Prostate Adenocarcinoma 2 Myofibroma 2 Endometriosis 2 Adenocarcinoma 2 Pathologic Complete Response 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1 Metastatic Castration-Resistant Prostate Cancer 1 Hormone Treatment-naïve Participants With Prostate Cancer 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02141659 2018-11-19

A Study of TAK-385 in Hormone Treatment-naïve Participants With Prostate Cancer

Takeda

Phase 1 Completed

43 enrolled 23 charts

Hormone Treatment-naïve Participants With Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡